[HTML][HTML] The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications

L Yang, G Liu, Y Li, Y Pan - Genes & Diseases, 2022 - Elsevier
The clinical study of nasopharyngeal carcinoma (NPC) often reveals a large number of
lymphocytes infiltrating the primary tumor site. As an important part of the tumor …

Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma

F Zhu, Y Wu, H Wang - Frontiers in Oncology, 2023 - frontiersin.org
Nasopharyngeal carcinoma (NPC) is a malignant tumor characterized by the malignant
transformation of nasopharyngeal epithelial cells. It is highly sensitive to radiation therapy …

Concurrent chemotherapy using taxane plus cisplatin versus cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction …

YN Zhang, YP Chen, JB Li, TX Lu… - … Advances in Medical …, 2023 - journals.sagepub.com
Background: Detectable Epstein–Barr virus (EBV) DNA levels and unsatisfactory tumor
response to induction chemotherapy (IC) could be used to guide the risk-adapted treatment …

Ⅱ~ Ⅳa 期鼻咽癌根治性放化疗—2021 年CSCO/ASCO 国际循证指南解读

周亚娟, 牟艳花, 胡德胜 - 肿瘤防治研究, 2021 - zlfzyj.com
Ⅱ~ Ⅳa 期鼻咽癌主要治疗方式是放疗联合化疗. 调强放射治疗时代, 化疗的介入时机与具体实施
仍存争议. 以往有关鼻咽癌的临床指南对于具体的放疗技术, 剂量分割以及放疗与化疗联合应用 …

[HTML][HTML] 雷替曲塞在消化系统肿瘤中的应用

涂欣鑫, 李钺 - Advances in Clinical Medicine, 2023 - hanspub.org
消化系统肿瘤是临床上常见的恶性肿瘤. 由于其起病隐匿, 进展快, 部分患者发现时已经错失手术
机会, 主要治疗方式为化疗为主的支持治疗. 主要化疗药物为5-氟尿嘧啶, 但由于5 …

Analysis of the curative effect and MRI imaging features of cisplatin concurrent radiotherapy and chemotherapy in the treatment of locally advanced nasopharyngeal …

J Wu, G Li, J Yang, J Li, X Yu… - Archives of Clinical …, 2023 - archivespsy.com
Objective To investigate the curative potential of concurrent cisplatin radiation and
chemotherapy in the management of locally advanced nasopharyngeal cancer and to …

子宮頸がん患者に対する同時化学放射線療法中のがんリハビリテーション実施率にかかわる要因の検討

原瑞帆, 広田桂介, 山下陽子, 神谷俊次, 市川博美… - 理学療法学, 2022 - jstage.jst.go.jp
[目的] 本研究は, 子宮頸がんにおける同時化学放射線療法 (以下, CCRT) を施行中の患者のがん
リハビリテーション (以下, がんリハ) 実施率とその要因を調査することを目的とした.[方法] 対象は …